Maternal and fetal brain contents of docosahexaenoic acid (DHA) and arachidonic acid (AA) at various essential fatty acid (EFA), DHA and AA dietary intakes during pregnancy in mice

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 78, Issue 3, 2008, Pages 159-169

  van Goor, Saskia A ^a   Dijck Brouwer, D A Janneke ^a   Fokkema, M Rebecca ^a   van der Iest, Theo Hans ^a   Muskiet, Frits A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DIET; DIETARY INTAKE; ERYTHROCYTE; FEMALE; FETOPLACENTAL UNIT; FETUS; MALE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; BRAIN; BRAIN CHEMISTRY; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, ESSENTIAL; FEMALE; FETUS; MICE; MICE, TRANSGENIC; PREGNANCY;

MUS;

EID: 41949120777     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.01.004     Document Type: Article

References (52)

1. Innis S.M. Essential fatty acids in growth and development. Prog. Lipid Res. 30 (1991) 39-103
2. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60 (2006) 502-507
3. de Lorgeril L.M., Salen P., Martin J.L., Monjaud I., Delaye J., and Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation 99 (1999) 779-785
4. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007) 1090-1098
5. Hibbeln J.R. Seafood consumption the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69 (2002) 15-29
6. Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry 67 (2006) 1954-1967
7. Sinclair A.J., Begg D., Mathai M., and Weisinger R.S. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pacific J. Clin. Nutr. 16 Suppl. 1 (2007) 391-397
8. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54 (1991) 438-463
9. Carlson S.E. Docosahexaenoic acid and arachidonic acid in infant development. Semin. Neonatol. 6 (2001) 437-449
10. Al M.D., van Houwelingen A.C., Kester A.D., Hasaart T.H., de Jong A.E., and Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 74 (1995) 55-68
11. Smuts C.M., Huang M., Mundy D., Plasse T., Major S., and Carlson S.E. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet. Gynecol. 101 (2003) 469-479
12. Al M.D., van Houwelingen A.C., and Hornstra G. Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur. J. Clin. Nutr. 51 (1997) 548-553
13. Bouwstra H., Dijck-Brouwer D.A., Decsi T., et al. Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids. Pediatr. Res. 60 (2006) 334-339
14. Hadders-Algra M. The role of long-chain polyunsaturated fatty acids (LCPUFA) in growth and development. Adv. Exp. Med. Biol. 569 (2005) 80-94
15. de Groot R.H., Adam J., Jolles J., and Hornstra. Alpha-linolenic acid supplementation during human pregnancy does not effect cognitive functioning. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 41-47
16. Carlson S.E. Arachidonic acid status of human infants: influence of gestational age at birth and diets with very long chain n-3 and n-6 fatty acids. J. Nutr. 126 (1996) 1092S-1098S
17. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., and Chance G.W. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 4 (1980) 121-129
18. Koletzko B., and Braun M. Arachidonic acid and early human growth: is there a relation?. Ann. Nutr. Metabol. 35 (1991) 128-131
19. Leaf A.A., Leighfield M.J., Costeloe K.L., and Crawford M.A. Long chain polyunsaturated fatty acids and fetal growth. Early Hum. Dev. 30 (1992) 183-191
20. Elias S.L., and Innis S.M. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids length of gestation, and birth weight and length. Am. J. Clin. Nutr. 73 (2001) 807-814
21. Auestad N., Montalto M.B., Hall R.T., et al. Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Ross pediatric lipid study. Pediatr. Res 41 (1997) 1-10
22. Wainwright P.E., Xing H.C., Ward G.R., et al. Water maze performance is unaffected in artificially reared rats fed diets supplemented with arachidonic acid and docosahexaenoic acid. J. Nutr. 129 (1999) 1079-1089
23. Muskiet F.A., van Doormaal J.J., Martini I.A., Wolthers B.G., and van der Slik W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J. Chromatogr. 278 (1983) 231-244
24. Volmer M., Meiborg G., and Muskiet F.A. Simultaneous capillary gas chromatographic profiling of medium- and long-chain fatty acid methyl esters with split injection. Correction for injection-related discrimination by the 'bracketing' method. J. Chromatogr. 434 (1988) 385-394
25. Rump P., and Hornstra G. Relation between arachidonic acid and docosahexaenoic acid in maternal and neonatal blood. Eur. J. Clin. Nutr. 55 (2001) 916-917
26. Stark K.D., Beblo S., Murthy M., et al. Comparison of bloodstream fatty acid composition from African-American women at gestation delivery, and postpartum. J. Lipid Res. 46 (2005) 516-525
27. Burdge G.C., Dunn R.L., Wootton S.A., and Jackson A.A. Effect of reduced dietary protein intake on hepatic and plasma essential fatty acid concentrations in the adult female rat: effect of pregnancy and consequences for accumulation of arachidonic and docosahexaenoic acids in fetal liver and brain. Br. J. Nutr. 88 (2002) 379-387
28. Burdge G.C., Sherman R.C., Ali Z., Wootton S.A., and Jackson A.A. Docosahexaenoic acid is selectively enriched in plasma phospholipids during pregnancy in Trinidadian women-results of a pilot study. Reprod. Nutr. Dev. 46 (2006) 63-67
29. Otto S.J., Houwelingen A.C., Antal M., et al. Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur. J. Clin. Nutr. 51 (1997) 232-242
30. Matorras R., Ruiz J.I., Perteagudo L., et al. Longitudinal study of fatty acids in plasma and erythrocyte phospholipids during pregnancy. J. Perinat. Med. 29 (2001) 293-297
31. Rump P., Mensink R.P., Kester A.D., and Hornstra G. Essential fatty acid composition of plasma phospholipids and birth weight: a study in term neonates. Am. J. Clin. Nutr. 73 (2001) 797-806
32. Vlaardingerbroek H., and Hornstra G. Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: comparison with plasma phospholipids. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 363-374
33. Otto S.J., van Houwelingen A.C., and Hornstra G. The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 323-328
34. Malcolm C.A., McCulloch D.L., Montgomery C., Shepherd A., and Weaver L.T. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch. Dis. Child Fetal Neonatal Ed. 88 (2003) F383-F390
35. Dunstan J.A., Mori T.A., Barden A., et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur. J. Clin. Nutr. 58 (2004) 429-437
36. Dijck-Brouwer D.A., Hadders-Algra M., Bouwstra H., et al. Impaired maternal glucose homeostasis during pregnancy is associated with low status of long-chain polyunsaturated fatty acids (LCP) and essential fatty acids (EFA) in the fetus. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005) 85-87
37. Muskiet F.A., van Goor S.A., Kuipers R.S., et al. Long-chain polyunsaturated fatty acids in maternal and infant nutrition. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 135-144
38. Carlson S.E., Carver J.D., and House S.G. High fat diets varying in ratios of polyunsaturated to saturated fatty acid and linoleic to linolenic acid: a comparison of rat neural and red cell membrane phospholipids. J. Nutr. 116 (1986) 718-725
39. Foote K.D., Hrboticky N., MacKinnon M.J., and Innis S.M. Brain synaptosomal liver, plasma, and red blood cell lipids in piglets fed exclusively on a vegetable-oil-containing formula with and without fish-oil supplements. Am. J. Clin. Nutr. 51 (1990) 1001-1006
40. Hrboticky N., MacKinnon M.J., and Innis S.M. Effect of a vegetable oil formula rich in linoleic acid on tissue fatty acid accretion in the brain, liver, plasma, and erythrocytes of infant piglets. Am. J. Clin. Nutr. 51 (1990) 173-182
41. Arbuckle L.D., Rioux F.M., MacKinnon M.J., Hrboticky N., and Innis S.M. Response of (n-3) and (n-6) fatty acids in piglet brain, liver and plasma to increasing but low, fish oil supplementation of formula. J. Nutr. 121 (1991) 1536-1547
42. Hsieh A.T., Anthony J.C., Diersen-Schade D.A., et al. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr. Res. (2007)
43. Makrides M., Neumann M.A., Byard R.W., Simmer K., and Gibson R.A. Fatty acid composition of brain retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60 (1994) 189-194
44. Carver J.D., Benford V.J., Han B., and Cantor A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 56 (2001) 79-85
45. Wainwright P.E., Xing H.C., Mutsaers L., McCutcheon D., and Kyle D. Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. J. Nutr. 127 (1997) 184-193
46. Al M.D., Hornstra G., van der Schouw Y.T., Bulstra-Ramakers M.T., and Huisjes H.J. Biochemical EFA status of mothers and their neonates after normal pregnancy. Early Hum. Dev. 24 (1990) 239-248
47. Kempe D.S., Lang P.A., Duranton C., et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 20 (2006) 368-370
48. Ghebremeskel K., Crawford M.A., Lowy C., et al. Arachidonic and docosahexaenoic acids are strongly associated in maternal and neonatal blood. Eur. J. Clin. Nutr. 54 (2000) 50-56
49. Brenna J.T., Varamini B., Jensen R.G., ersen-Schade D.A., Boettcher J.A., and Arterburn L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr. 85 (2007) 1457-1464
50. Kuipers R.S., Fokkema M.R., Smit E.N., van der M.J., Boersma E.R., and Muskiet F.A. High contents of both docosahexaenoic and arachidonic acids in milk of women consuming fish from lake Kitangiri (Tanzania): targets for infant formulae close to our ancient diet?. Prostaglandins Leukot. Essent. Fatty Acids 72 (2005) 279-288
51. Horrobin D.F., Jenkins K., Bennett C.N., and Christie W.W. Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. Prostaglandins Leukot. Essent. Fatty Acids 66 (2002) 83-90
52. Rao J.S., Ertley R.N., DeMar Jr. J.C., Rapoport S.I., Bazinet R.P., and Lee H.J. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 12 (2007) 151-157